Aurora Cannabis (ACB) Other financing activities (2018 - 2024)
Aurora Cannabis (ACB) posted quarterly Other financing activities of $39371.7 for Q4 2024, up 155.26% year-over-year from $15424.2 in Q1 2024, and up 141.0% quarter-over-quarter from -$96030.0 in Q3 2024.
Aurora Cannabis (ACB) Other financing activities (2018 - 2024) Analysis & Trends
Aurora Cannabis (ACB) has reported Other financing activities for 7 consecutive years, with $39371.7 the latest figure, recorded in Q4 2024.
- In Q4 2024, Other financing activities rose 155.26% year-over-year to $39371.7; the TTM figure through Dec 2024 stood at -$784472.5 (up 91.69% YoY), while the FY2023 annual figure was -$66256.3, up 99.73% from the prior year.
- Other financing activities rose to $39371.7 in Q4 2024 per ACB's latest filing, from -$96030.0 in the prior quarter.
- Across five years, Other financing activities topped out at $26.0 million in Q1 2022 and bottomed at -$25.5 million in Q3 2021.
- Historically, Other financing activities has averaged -$863321.4 across 5 years, with a median of -$83640.0 in 2023.
- Annual changes were most pronounced in 2020 — Other financing activities sank 35732.82% — and 2023, when it surged 1189.97%.
- Aurora Cannabis' Other financing activities stood at -$2.4 million in 2020, then surged by 105.26% to $127727.1 in 2021, then slumped by 8366.97% to -$10.6 million in 2022, then surged by 99.33% to -$71249.9 in 2023, then surged by 155.26% to $39371.7 in 2024.
- Business Quant data shows ACB's Other financing activities at $39371.7 in Q4 2024, -$96030.0 in Q3 2024, and -$656564.2 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Aurora Cannabis | 241.17 Mn | 168.86 Mn | 25.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39,371.70 |
| Dec 31, 2024 | 39,371.70 |
| Sep 30, 2024 | -96,030.00 |
| Sep 30, 2024 | -96,030.00 |
| Jun 30, 2024 | -656,564.21 |
| Jun 30, 2024 | -656,564.21 |
| Dec 31, 2023 | -71,249.95 |
| Dec 31, 2023 | -71,249.95 |
| Sep 30, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Dec 31, 2022 | -10.56 Mn |
| Dec 31, 2022 | -10.56 Mn |
| Sep 30, 2022 | -120,379.16 |
| Sep 30, 2022 | -120,379.16 |
| Jun 30, 2022 | -66,668.96 |
| Jun 30, 2022 | -66,668.96 |
| Mar 31, 2022 | 25.99 Mn |
| Mar 31, 2022 | 25.99 Mn |
| Dec 31, 2021 | 127,727.11 |
| Dec 31, 2021 | 127,727.11 |